MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
MUSTANG BIO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.37−0.00 (-0.90%)
Close on Oct 19, 2026
- Market cap
- $2.51M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.1270 (−75.13%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $2.51M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.33
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$3.03M
- EPS, diluted
- -$0.45
- Book value per share
- $1.12
- Diluted shares
- 7M
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Operating income
-$3.52M
Net income
-$3.03M
EPS, diluted
-$0.45
Free cash flow
–
Reported periodTrailing twelve months